-
Posted by
Two Blokes Jul 22 -
Filed in
Stock
-
7 views
hVIVO PLC (AIM:HVO) has reported revenues of £24.2 million for the first half of 2025, broadly in line with expectations for full-year revenues of £47 million, as the company continues to diversify its clinical services through recent acquisitions. Cavendish said the acquisitions of CRS and Cryostore contributed £5.2 million and £0.3 million respectively during the period.
